Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.66 and traded as low as $0.51. Medicure shares last traded at $0.53, with a volume of 3,000 shares traded.
Medicure Stock Performance
The business’s fifty day simple moving average is $0.57 and its 200 day simple moving average is $0.66. The company has a current ratio of 2.03, a quick ratio of 1.64 and a debt-to-equity ratio of 0.03. The stock has a market cap of $5.48 million, a P/E ratio of -3.75 and a beta of 0.98.
Medicure (OTCMKTS:MCUJF – Get Free Report) last issued its quarterly earnings data on Monday, November 25th. The company reported $0.05 EPS for the quarter. Medicure had a negative net margin of 9.62% and a negative return on equity of 10.12%.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- Using the MarketBeat Stock Split Calculator
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Stock Analyst Ratings and Canadian Analyst Ratings
- DuPont’s Electronics Spinoff: The Start of Something Big
- Pros And Cons Of Monthly Dividend Stocks
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.